Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M102Revenue $M44.3Net Margin (%)-1,957.1Altman Z-Score-48.3
Enterprise Value $M103EPS $-0.8Operating Margin %-1,887.8Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.5Pre-tax Margin (%)-1,977.2Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-59.1Quick Ratio1.4Cash flow > EarningsY
Price/Sales11.05-y EBITDA Growth Rate %-39.4Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-130.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,081.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M232ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell10,000$1.15-61.74view
BIANCO JAMES APresident and CEO 2016-01-29Sell10,000$1.2-63.33view
SINGER JACK WEVP, Chief Scientific Officer 2016-01-29Sell15,000$1.18-62.71view
BIOTECHNOLOGY VALUE FUND L P 2016-01-08Buy1,001,327$1.22-63.93view
Plunkett MatthewEVP, Chief Business Officer 2016-01-04Sell10,000$1.21-63.64view
BIANCO JAMES APresident and CEO 2015-12-30Sell110,000$1.26-65.08view
SINGER JACK WEVP Global Medical Affairs 2015-12-18Sell15,000$1.18-62.71view
Plunkett MatthewEVP, Corporate Development 2015-12-04Sell10,000$1-56view
BIANCO JAMES APresident and CEO 2015-11-27Sell10,000$1.23-64.23view
SINGER JACK WEVP, Global Medical Affairs 2015-11-27Sell15,000$1.21-63.64view

Quarterly/Annual Reports about CTIC:

    News about CTIC:

    Articles On GuruFocus.com
    Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
    Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
    Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

    More From Other Websites
    IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against CTI... Feb 08 2016
    Glancy Prongay & Murray Investigates Claims on Behalf of CTI BioPharma Corp. Investors Feb 08 2016
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of CTI BioPharma Corp.... Feb 08 2016
    Here's Why CTI BioPharma's Stock Lost 45% Feb 08 2016
    CTI BIOPHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements... Feb 08 2016
    3:36 am CTI BioPharma announces FDA Places Partial Clinical Hold on Pacritinib IND Feb 08 2016
    CTI BioPharma Provides Update On Investigational Agent Pacritinib Feb 08 2016
    CTI BioPharma Corp. breached its 50 day moving average in a Bearish Manner : February 3, 2016 Feb 03 2016
    CTI BioPharma (CTIC) in Focus: Stock Moves 5.9% Higher Feb 01 2016
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 28 2016
    CTI BioPharma Corp. – Value Analysis (NASDAQ:CTIC) : January 20, 2016 Jan 20 2016
    CTI BioPharma Corp. breached its 50 day moving average in a Bearish Manner : January 20, 2016 Jan 20 2016
    CTI BioPharma Appoints Matthew Perry To Board Of Directors Jan 13 2016
    CTI BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 13 2016
    CTI BioPharma Appoints Matthew Perry To Board Of Directors Jan 13 2016
    3 Biotech Stocks Under $10 to Trade for Big Breakouts Jan 13 2016
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 11 2016
    CTI BioPharma Announces Positive Progress Of Lead Clinical Programs And General Outlook For... Jan 11 2016
    CTI BIOPHARMA CORP Files SEC form 8-K, Other Events Jan 08 2016
    CTI BioPharma And Baxalta Complete Submission Of New Drug Application For Pacritinib For Unmet... Jan 05 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK